| Patent | Date |
|---|
Composition Of A 5-ht2a Serotonin Receptor Modulator Useful For The Treatment Of Disorders Related Thereto
App 20220160681 - Selvey; Lee Alani ; et al. | 2022-05-26 |
Methods For Preparing N-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)ph- Enylmethyl)carbamide And Its Tartrate Salt And Polymorphic Form C
App 20220024871 - Carlos; Marlon ; et al. | 2022-01-27 |
Crystalline L-arginine Salt Of (r)-2-(7-(4-cyclopentyl-3- (trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic Acid(compound1) For Use In Sipi Receptor-associated Disorders
App 20220002244 - Blackburn; Anthony C. ; et al. | 2022-01-06 |
Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in S1P.sub.1 receptor-associated disorders
Grant 11,091,435 - Blackburn , et al. August 17, 2 | 2021-08-17 |
Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)ph- enylmethyl)carbamide and its tartrate salt and polymorphic form C
Grant 10,981,871 - Carlos , et al. April 20, 2 | 2021-04-20 |
Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)ph- enylmethyl)carbamide and its tartrate salt and polymorphic form
Grant 10,981,870 - Carlos , et al. April 20, 2 | 2021-04-20 |
Composition Of A 5-ht2a Serotonin Receptor Modulator Useful For The Treatment Of Disorders Related Thereto
App 20200397753 - SELVEY; Lee Alani ; et al. | 2020-12-24 |
Crystalline L-arginine Salt Of (r)-2-(7-(4-cyclopentyl-3- (trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic Acid(compound1) For Use In Sipi Receptor-associated Disorders
App 20200361869 - Blackburn; Anthony C. ; et al. | 2020-11-19 |
Methods For Preparing N-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)ph- Enylmethyl)carbamide And Its Ta
App 20200181087 - Carlos; Marlon ; et al. | 2020-06-11 |
Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- yclo-penta [b]indol-3-yl)acetic acid(Compound 1) for use in SIPI receptor-associated disorders
Grant 10,676,435 - Blackburn , et al. | 2020-06-09 |
Methods For Preparing N-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)ph- Enylmethyl)carbamide And Its Ta
App 20200165202 - Carlos; Marlon ; et al. | 2020-05-28 |
Processes Useful For The Preparation Of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro- -phenyl)-urea
App 20200138784 - CARLOS; Marlon ; et al. | 2020-05-07 |
Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)ph- enylmethyl)carbamide and its tartrate salt and polymorphic form C
Grant 10,597,363 - Carlos , et al. | 2020-03-24 |
Composition of a 5-HT2A serotonin receptor modulator useful for the treatment of disorders related thereto
Grant 10,583,122 - Selvey , et al. | 2020-03-10 |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro- -phenyl)-urea and crystalline forms related thereto
Grant 10,543,193 - Carlos , et al. Ja | 2020-01-28 |
Crystalline L-arginine Salt Of (r)-2-(7-(4-cyclopentyl-3- (trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-
App 20190330153 - Blackburn; Anthony C. ; et al. | 2019-10-31 |
Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- yclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disorders
Grant 10,301,262 - Blackburn , et al. | 2019-05-28 |
Composition Of A 5-ht2a Serotonin Receptor Modulator Useful For The Treatment Of Disorders Related Thereto
App 20190099402 - SELVEY; Lee Alani ; et al. | 2019-04-04 |
Methods For Preparing N-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)ph- Enylmethyl)carbamide And Its Tartrate Salt And Polymorphic Form
App 20190047955 - Carlos; Marlon ; et al. | 2019-02-14 |
Processes Useful For The Preparation Of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro- -phenyl)-urea And Crystalline Forms Related Thereto
App 20180344698 - CARLOS; Marlon ; et al. | 2018-12-06 |
Composition of a 5-HT2A serotonin receptor modulator useful for the treatment of disorders related thereto
Grant 10,117,851 - Selvey , et al. November 6, 2 | 2018-11-06 |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro- -phenyl)-urea and crystalline forms related thereto
Grant 10,071,075 - Carlos , et al. September 11, 2 | 2018-09-11 |
Crystalline L-arginine Salt Of (r)-2-(7-(4-cyclopentyl-3- (trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic Acid(compound1) For Use In Sipi Receptor-associated Disorders
App 20180186738 - Blackburn; Anthony C. ; et al. | 2018-07-05 |
Composition Of A 5-ht2a Serotonin Receptor Modulator Useful For The Treatment Of Disorders Related Thereto
App 20180085351 - SELVEY; Lee Alani ; et al. | 2018-03-29 |
Processes Useful For The Preparation Of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro- -phenyl)-urea And Crystalline Forms Related Thereto
App 20180072680 - CARLOS; Marlon ; et al. | 2018-03-15 |
Composition of a 5-HT.sub.2A serotonin receptor modulator useful for the treatment of disorders related thereto
Grant 9,801,856 - Selvey , et al. October 31, 2 | 2017-10-31 |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro- -phenyl)-urea and crystalline forms related thereto
Grant 9,745,270 - Carlos , et al. August 29, 2 | 2017-08-29 |
Processes Useful For The Preparation Of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro- -phenyl)-urea And Crystalline Forms Related Thereto
App 20170057924 - Carlos; Marlon ; et al. | 2017-03-02 |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro- -phenyl)-urea and crystalline forms related thereto
Grant 9,353,064 - Carlos , et al. May 31, 2 | 2016-05-31 |
Composition Of A 5-ht2a Serotonin Receptor Modulator Useful For The Treatment Of Disorders Related Thereto
App 20160067216 - Selvey; Lee Alani ; et al. | 2016-03-10 |
Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro- -phenyl)urea and crystalline forms related thereto
Grant 9,126,946 - Carlos , et al. September 8, 2 | 2015-09-08 |
Processes Useful For The Preparation Of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro- -phenyl)-urea And Crystalline Forms Related Thereto
App 20150210648 - CARLOS; Marlon ; et al. | 2015-07-30 |
Composition of a 5-HT.sub.2A serotonin receptor modulator useful for the treatment of disorders related thereto
Grant 9,034,911 - Selvey , et al. May 19, 2 | 2015-05-19 |
Processes for preparing (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates thereof
Grant 8,299,241 - Gharbaoui , et al. October 30, 2 | 2012-10-30 |
Processes For The Preparation Of 5-ht2c Receptor Agonists
App 20120142967 - DeMattei; John A. ; et al. | 2012-06-07 |
Composition Of A 5-ht2a Serotonin Receptor Modulator Useful For The Treatment Of Disorders Related Thereto
App 20110207791 - Selvey; Lee Alani ; et al. | 2011-08-25 |
Processes Useful For The Preparation Of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro- -phenyl)urea And Crystalline Forms Related Thereto
App 20110207790 - Carlos; Marlon ; et al. | 2011-08-25 |
Processes For Preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine And Intermediates Thereof
App 20100305316 - Gharbaoui; Tawfik ; et al. | 2010-12-02 |
Processes for preparing pyrazolo[3,4-d]pyrimidine ethers
Grant 7,425,630 - Gharbaoui , et al. September 16, 2 | 2008-09-16 |
Processes for preparing pyrazolo[3,4-d]pyrimidine ethers
App 20060154940 - Gharbaoui; Tawfik ; et al. | 2006-07-13 |
| 